The promise of high-performance reconfigurable computing is finally being realized on a commercial scale through a combination of unrelenting advances in lower power, extreme performance programmable logic architectures and the new software programming paradigm, characterized by electronic system level (ESL) design, that enables these architectures to be more easily exploited and integrated into high-performance computing (HPC) infrastructures and systems.
Working with industry, Celoxica is already deploying its award-winning ESL design solutions and acceleration cards to enable HPC and DSP designers take maximum advantage of the parallel processing capabilities of FPGA, either as software-programmable custom processors or co-processors that augment existing solutions such as high-end DSP or microprocessor technology. The research agreement with UTIA will help accelerate the development of Celoxica's next generation solutions.
"Our continued program of invention and innovation requires continued investment and we have carefully selected UTIA as a long-term research partner to augment our internal R&D efforts," said Phil Bishop, president and CEO of Celoxica. "The team at UTIA brings a wealth of knowledge, expertise and creativity that will help us develop solutions that further push the boundaries of accelerated computing and next generation programmable logic design."
Jiri Kadlec, head of signal processing and distinguished researcher in reconfigurable signal processing technology, commented, "There is now commercial recognition of how massively parallel, reconfigurable hardware processing architectures can be practically used to solve some of the issues that surround complex computing problems. Our research has helped define the solutions to these problems and with the availability of software programmable hardware we can now focus effort on the underlying mathematical calculations that will drive commercial applications."
A leader in electronic system level design (ESL), Celoxica is enabling the next generation of advanced electronic products by producing tools, boards, IP and services that turn software into silicon. Celoxica technology raises design abstraction to the algorithm level, accelerating productivity and lowering risk and costs by generating semiconductor hardware directly from C-based software descriptions. Adding to a growing installed base, Celoxica provides the world's most widely used C-based behavioral design and synthesis solutions to companies developing semiconductor products in markets such as consumer electronics, defense and aerospace, automotive, industrial and security. Celoxica is a publicly traded company on the Alternative Investment Market of the London Stock Exchange under the symbol CXA. For more information, visit: www.celoxica.com.
The mission of The institute is to provide the basic research in the fields of theoretical cybernetics and computer science, namely the control science, information science, advanced data and knowledge processing, system science and signal processing. Attention is paid to the problems connected with application of these branches and to the education and propagation of new results
About The Academy of Sciences of the Czech Republic (ASCR)
The Academy of Sciences of the Czech Republic (ASCR) was established in 1992 by the Czech National Council (Act No. 283/1992 of the Collection of Acts) as the Czech successor of the former Czechoslovak Academy of Sciences. ASCR is the leading non-university basic research public institution in the Czech Republic. It conducts both fundamental and strategic applied research to create scientific knowledge that contributes to strengthening the nation's position in key areas of science and to finding up-to-date solutions to contemporary problems of the society.
Within three Scientific Divisions, namely the Division of Mathematics, Physics, and Earth Sciences, Division of Chemical and Life Sciences, and Division of Humanities and Social Sciences, the Academy currently manages a network of sixty research institutes and five supporting units staffed by a total of 6400 employees, of whom slightly over one half are university-trained researchers and Ph.D. scientists. The ASCR institutes are also involved in education by providing courses at the graduate level and supervising doctoral programs. The Head Office of the Academy and forty research institutes are located in Prague, the remaining institutes being situated throughout the country.
Celoxica and the Celoxica logo are trademarks of Celoxica, Ltd. All other brand names and product names are the property of their respective owners
Celoxica Ltd. Jeff Jussel, 512-795-8170 Email Contact or VitalCom Marketing & PR Lou Covey, 650-366-8212 Email Contact or Neesham PR Peter van der Sluijs, +44-1296-628-180 Email Contact